IntraLase Names Richard Nye VP Operations

    Business Editors/Health/Medical Writers

    IRVINE, Calif.--(BUSINESS WIRE)--May 9, 2005--IntraLase Corp. (Nasdaq:ILSE) today announced it has named Richard Nye Vice President of Operations. Nye will be responsible for laser and patient interface manufacturing, global supply-chain management, producibility engineering and facilities. Nye will report to Charline Gauthier, executive vice president and chief operating officer.
    Nye has more than 20 years of manufacturing experience, principally in the medical device industry, where he developed the skills to apply world-class manufacturing principles and teamwork to manufacturing and supply-chain management. He has a proven track record in the areas of lean manufacturing, process improvement and project management.
    "We are proud of our reputation for manufacturing excellence, and Dick will instill a culture of continuous process improvement to make certain that we are always regarded as a high-quality manufacturer," Gauthier said. "He also has experience in relocating manufacturing operations, which will help to ensure a seamless move into our new facility mid-year."
    Nye joins IntraLase from Tyco Healthcare's Kendall division where, as a manufacturing vice president for this division with annual sales of $576 million, he was directly responsible for nine manufacturing sites and 3,100 employees in five countries. Before that, he held several positions in manufacturing with Mallinckrodt Inc., which was acquired by Tyco Healthcare in 2001.
    Nye earned a bachelor's degree in mechanical engineering from Michigan Technological University and a master's in business from Washington University in St. Louis.

    Forward-Looking Statements:

    Statements contained in this press release that are not historical information are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as "believe," "expect," "anticipate," "intend," "plan," "estimate," "project," or words of similar meaning, or future or conditional verbs such as "will," "would," "should," "could," or "may." Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected or implied. Those risks and uncertainties include, but are not limited to: the degree of continued acceptance of LASIK surgery; potential complications revealed by long term follow up; the extent of adoption of our product offering by LASIK surgeons; general economic conditions; changes in federal tax laws governing the ability of potential LASIK patients to use pre-tax dollars to pay for LASIK surgery; the scope of government regulation applicable to our products; patients' willingness to pay for LASIK surgery; our ability to compete against our competitors; the effectiveness of our measures to ensure full payment of procedure fees; the occurrence and outcome of product liability suits against us; our ability to adequately protect our intellectual property; whether we become subject to claims of infringement or misappropriation of the intellectual property rights of others; the continued availability of supplies from single-source suppliers and manufacturers of our key laser components; the ability of our managers, operations and facilities to manage our growth; the success of our expansion into markets outside the United States; whether we lose any of our key executives or fail to attract qualified personnel; or if our new products or applications fail to become commercially viable.
    Certain of these risks and uncertainties, in addition to other risks, are more fully described in the company's annual report on form 10-K for the period ending Dec. 31, 2004, as filed with the Securities and Exchange Commission on March 29, 2005.
    These forward-looking statements are made only as of the date of this press release, and the company assumes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

    About IntraLase Corp.:

    IntraLase designs, develops and manufactures an ultra-fast laser, related software and disposable devices used to create a corneal flap, the first step in LASIK surgery for the correction of vision. The company's products improve the safety, precision and visual results of LASIK procedures by providing a computer-controlled laser solution in place of the hand-held mechanical, metal-bladed microkeratome traditionally used to create corneal flaps. IntraLase lasers are also used in surgical approaches to the treatment of diseased corneas. The company's lasers and disposable per procedure patient interfaces are presently marketed throughout the United States and 19 other countries. IntraLase has headquarters and manufactures its products in Irvine. For additional information, visit the company's Web site: www.intralase.com.

--30--ST/np*

CONTACT: IntraLase Corp. Shelley B. Thunen, 949-859-5230 x196 sthunen@intralase.com or Financial Relations Board Marilyn Windsor, 702-515-1260 mwindsor@financialrelationsboard.com

KEYWORD: CALIFORNIA INDUSTRY KEYWORD: PHARMACEUTICAL MEDICAL MEDICAL DEVICES MANAGEMENT CHANGES SOURCE: IntraLase Corp.

Copyright Business Wire 2005